glp 1 deal Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk it helps increase faecal bulk for digestive comfort Weight-loss drug makers announce pricing

43% cover Food and Drug Adminstration-approved weight loss medications and 28% may in the next one to two years

Are compounded GLP-1s safe after the February 2026 FDA warning letters

This brief describes current coverage of GLP-1s in Medicare and Medicaid, the Centers for Medicare & Medicaid Services (CMS) efforts to expand access and lower costs for GLP-1s through temporary demonstration programs, and potential impacts on beneficiaries and program budgets

The FDA warned seven companies to stop selling unapproved eye drops

GH secretagogue users start seeing measurable body composition changes, with waist circumference typically decreasing before scale weight changes significantly